Albert Batalla
Overview
Explore the profile of Albert Batalla including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
827
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cinar B, Ligthart S, de Wit H, Schellekens A, Fleuren H, Kramers C, et al.
BJGP Open
. 2025 Mar;
PMID: 40074288
Background: Quetiapine, an antipsychotic, is registered for schizophrenia, bipolar disorder, and as an add-on therapy for major depressive disorder. Its anxiolytic and sedative effects make it attractive for off-label uses...
2.
Camma G, Verdouw M, van der Meer P, Groenink L, Batalla A
Eur Neuropsychopharmacol
. 2024 Nov;
91:9-24.
PMID: 39541799
Interest in cannabinoids' therapeutic potential in mental health is growing, supported by evidence of the involvement of the endocannabinoid system in psychiatric disorders such as anxiety, depression, and addiction. While...
3.
Leen N, Kowal M, Batalla A, Bossong M
Front Pharmacol
. 2024 Nov;
15:1411631.
PMID: 39484170
Introduction: There is growing recognition of the potential of cannabis to treat various medical conditions and symptoms, such as chronic pain, spasticity, and epilepsy. However, one of the biggest challenges...
4.
Gomez-Escolar A, Folch-Sanchez D, Stefaniuk J, Swithenbank Z, Nisa A, Braddick F, et al.
CNS Drugs
. 2024 Jul;
38(10):771-789.
PMID: 39033264
Mental health disorders and substance use disorders (SUDs) in particular, contribute greatly to the global burden of disease. Psychedelics, including entactogens and dissociative substances, are currently being explored for the...
5.
Bueno L, Batalla A, Balcells M, Lopez-Pelayo H
Eur Neuropsychopharmacol
. 2024 Jul;
87:27.
PMID: 39032391
No abstract available.
6.
Stampf A, Schwarzkopf L, Batalla A, Feingold D, Fischer B, Hoch E
Eur Arch Psychiatry Clin Neurosci
. 2024 Jul;
275(2):365-378.
PMID: 38951248
Post-2000, the prevalence of cannabis consumption has been rising internationally. This paper investigates whether cannabis-related treatment demand in German outpatient addiction care facilities (OACFs) has been following this trend. Treatment...
7.
Lorenzetti V, Gaillard A, McTavish E, Grace S, Rossetti M, Batalla A, et al.
Cannabis Cannabinoid Res
. 2024 Mar;
9(6):e1565-e1578.
PMID: 38498015
Males and females who consume cannabis can experience different mental health and cognitive problems. Neuroscientific theories of addiction postulate that dependence is underscored by neuroadaptations, but do not account for...
8.
Fortea A, van Eijndhoven P, Calvet-Mirabent A, Ilzarbe D, Batalla A, de la Serna E, et al.
Eur Child Adolesc Psychiatry
. 2023 Aug;
33(6):1837-1846.
PMID: 37644217
Progression to psychosis has been associated with increased cortical thinning in the frontal, temporal and parietal lobes in individuals at clinical high risk for the disorder (CHR-P). The timing and...
9.
Bramness J, Leonhardt M, Dom G, Batalla A, Florez Menendez G, Mann K, et al.
Eur Addict Res
. 2023 Aug;
30(3):127-137.
PMID: 37557089
Introduction: Training in addiction medicine and addiction psychology is essential to ensure the quality of treatment for patients with substance use disorders. Some earlier research has shown varying training between...
10.
van der Meer P, Dirven L, Hertler C, Boele F, Batalla A, Walbert T, et al.
Neurooncol Pract
. 2023 Jul;
10(4):335-343.
PMID: 37457222
AbstractGlioma patients carry the burden of having both a progressive neurological disease and cancer, and may face a variety of symptoms, including depression and anxiety. These symptoms are highly prevalent...